The Global Bioresorbable Surgical Material Market was valued at USD 2.8 Billion in 2024 and is projected to reach USD 5.1 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 10.5% during the forecast period (2024–2030). This significant growth is primarily driven by the rising demand for minimally invasive surgeries, advancements in polymer science, and an increasing focus on eliminating the need for secondary surgeries to remove implants.

As the healthcare industry pivots toward patient-centric solutions that promote natural healing, bioresorbable materials are becoming the gold standard in various surgical applications. These materials, which safely dissolve in the body over time, are revolutionizing orthopedics, drug delivery, and tissue engineering. In this blog, we profile the Top 10 Companies in the Bioresorbable Surgical Material Industry—a blend of established chemical giants, specialized medical polymer producers, and innovative healthcare-focused firms shaping the future of surgical care.

---

🔟 1. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: RESOMER® polymers (PLA, PLGA, PCL), custom biomaterials

Evonik is a global leader in specialty chemicals and a pioneer in the development of bioresorbable polymers. Its RESOMER® brand is one of the most recognized families of biomaterials worldwide, used in a vast array of medical devices, including sutures, screws, pins, and advanced drug delivery systems.

Innovation Initiatives:

• Extensive R&D portfolio for next-generation resorbable polymers

• Strategic partnerships with medical device OEMs for co-development

• Focus on tailoring degradation rates and mechanical properties for specific clinical applications

Download FREE Sample Report: Bioresorbable Surgical Material Market – View in Detailed Research Report

---

9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: Purasorb® (PLA, PGA), Luminy® PLA polymers

Corbion is a leading supplier of lactic acid及其衍生物, which are the foundational building blocks for polylactic acid (PLA) polymers. The company’s high-purity Purasorb® polymers are designed specifically for demanding medical applications, offering excellent biocompatibility and controlled resorption profiles.

Innovation Initiatives:

• Investment in expanding bio-based polymer production capacity

• Development of high-performance PLA copolymers for enhanced functionality

---

8️⃣ 3. DSM Biomedical

Headquarters: Heerlen, Netherlands
Key Offering: Bioresorbable polymers for stents, scaffolds, and soft tissue repair

DSM Biomedical leverages its deep material science expertise to create innovative resorbable solutions. The company specializes in developing materials for vascular applications, including bioresorbable vascular scaffolds (BVS), and offers technology platforms for drug-eluting medical devices.

Innovation Initiatives:

• Proprietary polymer platforms for controlled drug release

• Collaborations focusing on cardiovascular and orthopedic regenerative medicine

---

7️⃣ 4. Mitsui Chemicals, Inc.

Headquarters: Tokyo, Japan
Key Offering: LACTEL® Absorbable Polymers, PURASORB®

Through its subsidiary, Purac Biochem (now part of Corbion), and its own development, Mitsui Chemicals is a significant force in the absorbable polymer market. The company’s materials are critical components in a wide range of surgical meshes, fixation devices, and pharmaceutical formulations.

Innovation Initiatives:

• Integration of bio-based feedstocks into polymer synthesis

• Focus on enhancing the mechanical strength and processing of resorbable polymers

Download FREE Sample Report: Bioresorbable Surgical Material Market – View in Detailed Research Report

---

6️⃣ 5. PCAS

Headquarters: Longjumeau, France
Key Offering: High-purity intermediates and complex molecules for resorbable polymers

PCAS specializes in the development and production of complex molecules, including those used in synthesizing advanced bioresorbable materials. The company serves as a key partner for pharmaceutical and medical device companies, providing the critical building blocks needed for innovative implantable devices.

Innovation Initiatives:

• Expertise in the synthesis of custom monomers for tailored degradation

• Contract development and manufacturing services for the medical industry

---

5️⃣ 6. Poly-Med, Inc.

Headquarters: Anderson, South Carolina, USA
Key Offering: Broad portfolio of absorbable polymers and finished medical devices

Poly-Med is a vertically integrated company dedicated exclusively to absorbable technology. It not only develops a wide array of resorbable polymers but also designs and manufactures finished medical devices, such as surgical meshes, screws, and anastomosis products, offering a unique end-to-end solution.

Innovation Initiatives:

• Proprietary polymer systems with tunable absorption profiles (e.g., segmented copolymers)

• In-house device manufacturing from polymer synthesis to final sterilization

---

4️⃣ 7. KLS Martin Group

Headquarters: Tuttlingen, Germany
Key Offering: Bioresorbable fixation systems for craniomaxillofacial (CMF) and orthopedic surgery

KLS Martin is a renowned medical device company that heavily integrates bioresorbable materials into its product lines. The company’s RESORB X® and other resorbable plating systems are widely used in facial reconstruction and pediatric surgeries, where implant removal is undesirable.

Innovation Initiatives:

• Development of composite materials combining strength with predictable resorption

• Focus on patient-specific solutions using bioresorbable materials

---

3️⃣ 8. Medtronic plc

Headquarters: Dublin, Ireland
Key Offering: Bioresorbable matrices, sutures, and cardiac rhythm management devices with resorbable components

As a global healthcare solutions leader, Medtronic extensively utilizes bioresorbable materials across its diverse portfolio. From the ARTISENTIAL® laparoscopy portfolio with resorbable staples to advanced wound care and spinal products, Medtronic is at the forefront of applying this technology to improve patient outcomes.

Innovation Initiatives:

• Integration of resorbable materials in next-generation surgical robotics platforms

• R&D into bioresorbable electronics and sensors for temporary monitoring

---

2️⃣ 9. Johnson & Johnson (DePuy Synthes)

Headquarters: New Brunswick, New Jersey, USA
Key Offering: BIOJACKEK® screw system, VICRYL® (polyglactin 910) sutures

Johnson & Johnson’s medical device division, particularly DePuy Synthes, is a powerhouse in the orthopedic and surgical markets. The company offers some of the most widely used bioresorbable products, such as VICRYL sutures, and continues to innovate with composite interference screws and other fixation devices that support healing without long-term foreign body presence.

Innovation Initiatives:

• Development of reinforced composite materials for load-bearing applications

• Clinical research on long-term outcomes of bioresorbable implants

---

1️⃣ 10. Stryker Corporation

Headquarters: Kalamazoo, Michigan, USA
Key Offering: Bioresorbable anchors, screws, and meshes for sports medicine and trauma

Stryker is a leading player in the medtech space, with a strong focus on orthopedics. Its bioresorbable portfolio includes the popular BIOKNOTLESS® and GII ANCHOR systems used in soft tissue repair. These implants provide initial fixation strength and then gradually transfer load to the healing tissue as they resorb.

Innovation Initiatives:

• Advancements in osteoconductive materials that encourage bone in-growth

• Utilization of bioresorbables in minimally invasive surgical techniques

Get Full Report Here: Bioresorbable Surgical Material Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Surgery Is Temporary and Smart

The bioresorbable surgical material market is transitioning from basic fixation devices to sophisticated, multifunctional implants. The next generation of materials will not just dissolve; they will actively participate in the healing process by releasing drugs, providing mechanical cues to cells, and integrating seamlessly with native tissue.

📈 Key Trends Shaping the Market:

• Rise of composite materials combining polymers with ceramics (e.g., hydroxyapatite) for bone regeneration

• Growth in 3D printing (additive manufacturing) of patient-specific resorbable implants

• Expansion into new therapeutic areas such as neurosurgery and cardiac tissue engineering

• Increasing regulatory focus on long-term biocompatibility and degradation by-products

Get Full Report Here: Bioresorbable Surgical Material Market – View in Detailed Research Report

The companies listed above are not only supplying materials—they are enabling a fundamental shift toward more natural, less invasive, and patient-friendly surgical outcomes.